STRUCTURE OF MAIN REASONS OF LETHALITY OF SCHIZOPHRENIC PATIENTS IN THE CITY (2007-2013)

Abstract

There were studied and statistically processed the archives of the psychiatric hospitals of Moscow, during the period 2007-2013 of 296 died schizophrenic patients. There was described the somatic morbidity rate at the moment of admission to hospital, causes of death and age mortality peculiarities of schizophrenic patients. It was demonstrated the prevalence of cardiovascular disorders, respiratory diseases and oncopathology that lead to death of schizophrenic patients.

Keywords

Mental illness / mortality / morbidity / schizophrenia

References

[1] Волков В.П. Соматическая патология и причины смерти при шизофрении // Журнал неврологии и психиатрии. 2009. Т. 109, № 5. С. 14-19.

[2] Калабеков И.Г. Российские реформы в цифрах и фактах (справочное издание). М.: РУСАКИ, 2007. С. 288

[3] Максимова Н. Е. Катамнестическое исследование диспансерной когорты психически больных в возрасте старше 60 лет // Казанский мед. ж. 2006. №6. C. 469-472

[4] Менделевич Б.Д., Куклина А.М. К вопросу о распространённости соматической патологии среди пациентов, страдающих психическими расстройствами // Казанский мед. ж. 2012. №3. С. 532-534

[5] Смертность населения Российской Федерации - 2002 г. (Статист. мат. МЗ РФ). М., 2003 (и за 1991-2000 гг.)

[6] Brown S. Excess mortality of schizophrenia. A meta-analysis // D.J. Psychiatry. 1997. Vol. 171. P. 502-508

[7] Brown S., Inskip H., Barracloungh B. Causes of the excess mortality of schizophrenia // Br. J. Psychiatry. 2000. Vol. 177. P 212-217

[8] Bushe C., Taylor M., Haukka J. Mortality in schizophrenia - A measurable clinical endpoint // J. Psychopharmacol. 2010. Vol. 24 (Suppl 4). P. 17-25

[9] De Hert M., Dekker J.M., Wood D. et al. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and European Society of Cardiology (ESC) // Eur. Psychiatry. 2009. Vol. 24, N 6. P. 412-424

[10] Fors B.M., Isacson D., Bingefors K., Widerlov B. Mortality among persons with schizophrenia in Sweden: an epidemiological study // Nord. J. Psychiatry. 2007. Vol. 61. P. 252-259

[11] Harris E.C., Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis // D.J. Psychiatry. 1997. Vol. 170. P. 205-228

[12] Killian J.G., Kerr K., Lawrence C. et al. Myocarditis and cardiomyopathy associated with clozapine // Lancet. 1999. Vol. 354. P. 1841-1845

[13] Laursen T.M., Nordentoft M. Heart disease treatment and mortality in schizophrenia and bipolar disorder changes in the danish population between 1994 and 2006 // J. Psych. Res. 2011. Vol. 45. P. 29-35

[14] Lawrence D., Kisely S., Pais J. The epidemiology of excess mortality in people with mental illness // Can. J. Psychiatry. 2010. Vol. 55, № 12. P. 752-759

[15] Osby U., Correia N., Brandt L. et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden // Psych. Res. 2000. Vol. 45. P. 21-28

[16] Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? // Arch. Gen. Psychiatry. 2007. Vol. 64. P. 1123-1131

[17] Tiihonen J., Suokas J.T., Suvisaari J.M., Haukka J., Korhonen P. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia // Arch Gen Psychiatry. 2012 May. Vol. 69(5). P. 476-483

RIGHTS & PERMISSIONS

Shepin V.O., Masyakin A.V.